Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
Int J Cancer
    December 2017
  1. FENG HC, Lin JY, Hsu SH, Lan WY, et al
    Low folate metabolic stress reprograms DNA methylation-activated sonic hedgehog signaling to mediate cancer stem cell-like signatures and invasive tumour stage-specific malignancy of human colorectal cancers.
    Int J Cancer. 2017;141:2537-2550.
    >> Share

    November 2017
  2. DI J, Yang H, Jiang B, Wang Z, et al
    Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31140.
    >> Share

    October 2017
  3. ZHANG QL, Zhao LG, Li HL, Gao J, et al
    The joint effects of major lifestyle factors on colorectal cancer risk among Chinese men: A prospective cohort study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31126.
    >> Share

  4. HOLCH JW, Ricard I, Stintzing S, Fischer von Weikersthal L, et al
    Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31114.
    >> Share

  5. NIELL N, Larriba MJ, Ferrer-Mayorga G, Sanchez-Perez I, et al
    The human PKP2/Plakophilin-2 gene is induced by Wnt/beta-catenin in normal and colon cancer-associated fibroblasts.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31104.
    >> Share

  6. HIDAYAT K, Yang CM, Shi BM
    Body Fatness at an Early Age and Risk of Colorectal Cancer.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31100.
    >> Share

  7. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    >> Share

  8. VARGAS-PARRA GM, Gonzalez-Acosta M, Thompson BA, Gomez C, et al
    Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Int J Cancer. 2017;141:1365-1380.
    >> Share

    September 2017
  9. TANSKANEN T, van den Berg L, Valimaki N, Aavikko M, et al
    Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
    Int J Cancer. 2017 Sep 28. doi: 10.1002/ijc.31076.
    >> Share

  10. POTHOULAKIS C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, et al
    CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31064.
    >> Share

  11. WANG W, Xiao X, Chen X, Huo Y, et al
    Tumor-suppressive miR-145 co-repressed by TCF4-beta-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31056.
    >> Share

  12. JAYASEKARA H, English DR, Haydon A, Hodge AM, et al
    Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31049.
    >> Share

  13. HASENOEHRL C, Feuersinger D, Sturm EM, Barnthaler T, et al
    G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31030.
    >> Share

  14. MA B, Gao P, Wang H, Xu Q, et al
    What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
    Int J Cancer. 2017;141:1052-1065.
    >> Share

  15. VEDELD HM, Merok M, Jeanmougin M, Danielsen SA, et al
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Int J Cancer. 2017;141:967-976.
    >> Share

    August 2017
  16. MOMEN-HERAVI F, Masugi Y, Qian ZR, Nishihara R, et al
    Tumor Expression of Calcium Sensing Receptor (CASR) and Colorectal Cancer Survival: Results from the Nurses' Health Study and Health Professionals Follow-Up Study.
    Int J Cancer. 2017 Aug 30. doi: 10.1002/ijc.31021.
    >> Share

  17. EKLOF V, Lofgren-Burstrom A, Zingmark C, Edin S, et al
    Cancer associated faecal microbial markers in colorectal cancer detection.
    Int J Cancer. 2017 Aug 22. doi: 10.1002/ijc.31011.
    >> Share

  18. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    >> Share

  19. MEESTER RGS, Doubeni CA, Zauber AG, van Ballegooijen M, et al
    Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30933.
    >> Share

  20. JUBRAN R, Kocsis J, Garam N, Malati E, et al
    Circulating mitochondrial Stress-70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30918.
    >> Share

    July 2017
  21. JIAO W, Leng X, Zhou Q, Wu Y, et al
    Different miR-21-3p isoforms and their different features in colorectal cancer.
    Int J Cancer. 2017 Jul 22. doi: 10.1002/ijc.30902.
    >> Share

  22. SCHIRRIPA M, Zhang W, Heinemann V, Cao S, et al
    Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
    Int J Cancer. 2017;141:383-392.
    >> Share

  23. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    >> Share

  24. BERNTSSON J, Svensson MC, Leandersson K, Nodin B, et al
    The Clinical Impact of Tumour-infiltrating Lymphocytes in Colorectal Cancer Differs by Anatomical Subsite: A Cohort Study.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30869.
    >> Share

  25. KRILAVICIUTE A, Stock C, Brenner H
    International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30867.
    >> Share

  26. ALAM KJ, Mo JS, Han SH, Park WC, et al
    MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30861.
    >> Share

  27. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    >> Share

    June 2017
  28. LAUDATO S, Patil N, Abba ML, Leupold JH, et al
    P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30854.
    >> Share

  29. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Secombe KR, et al
    Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
    Int J Cancer. 2017;140:2820-2829.
    >> Share

  30. YANG Y, Wang G, He J, Ren S, et al
    Gender differences in colorectal cancer survival: A Meta-analysis.
    Int J Cancer. 2017 Jun 9. doi: 10.1002/ijc.30827.
    >> Share

    May 2017
  31. OKAZAKI S, Stintzing S, Sunakawa Y, Cao S, et al
    Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30810.
    >> Share

  32. WANG N, Lu Y, Khankari NK, Long J, et al
    Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30812.
    >> Share

  33. CANAVESE M, Ngo DT, Maddern GJ, Hardingham JE, et al
    Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.
    Int J Cancer. 2017;140:2183-2191.
    >> Share

  34. SNAEBJORNSSON P, Jonasson L, Olafsdottir EJ, van Grieken NCT, et al
    Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30766.
    >> Share

  35. BUTT J, Werner S, Willhauck-Fleckenstein M, Michel A, et al
    Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30765.
    >> Share

  36. BRENNER H, Niedermaier T, Chen H
    Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
    Int J Cancer. 2017;140:2015-2022.
    >> Share

    April 2017
  37. BJERRUM A, Andersen O, Fischer A, Lindebjerg J, et al
    Long term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30756.
    >> Share

  38. SENDA NAKAGAWA H, Ito H, Hosono S, Oze I, et al
    Coffee consumption and the risk of colorectal cancer by anatomical subsite in Japan: Results from the HERPACC studies.
    Int J Cancer. 2017 Apr 20. doi: 10.1002/ijc.30746.
    >> Share

  39. MODEST DP, Stintzing S, Fischer von Weikersthal L, Decker T, et al
    Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
    Int J Cancer. 2017;140:1918-1925.
    >> Share

  40. BEDIN C, Enzo MV, Del Bianco P, Pucciarelli S, et al
    Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Int J Cancer. 2017;140:1888-1898.
    >> Share

  41. ROMAGUERA D, Gracia-Lavedan E, Molinuevo A, de Batlle J, et al
    Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30722.
    >> Share

  42. JANSEN L, Weberpals J, Kuiper JG, Vissers PA, et al
    Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30717.
    >> Share

  43. JAYASEKARA H, MacInnis RJ, Williamson EJ, Hodge AM, et al
    Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
    Int J Cancer. 2017;140:1485-1493.
    >> Share

  44. KUAN FC, Lai CH, Ku HY, Wu CF, et al
    The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Int J Cancer. 2017;140:1662-1669.
    >> Share

  45. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    >> Share

    March 2017
  46. RODRIGUEZ-BROADBENT H, Law PJ, Sud A, Palin K, et al
    Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30709.
    >> Share

  47. ZHU XH, Wang JM, Yang SS, Wang FF, et al
    Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30701.
    >> Share

  48. ZHANG L, Li L, Gao G, Wei G, et al
    Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Int J Cancer. 2017 Mar 17. doi: 10.1002/ijc.30698.
    >> Share

  49. DIETER SM, Giessler KM, Kriegsmann M, Dubash TD, et al
    Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Int J Cancer. 2017;140:1356-1363.
    >> Share

  50. WILHELMSEN M, Christensen IJ, Rasmussen L, Jorgensen LN, et al
    Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Int J Cancer. 2017;140:1436-1446.
    >> Share

  51. WANG H, Schmit SL, Haiman CA, Keku TO, et al
    Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.
    Int J Cancer. 2017 Mar 13. doi: 10.1002/ijc.30687.
    >> Share

  52. FIDLER MM, Bray F, Vaccarella S, Soerjomataram I, et al
    Assessing global transitions in human development and colorectal cancer incidence.
    Int J Cancer. 2017 Mar 9. doi: 10.1002/ijc.30686.
    >> Share

  53. KEUM N, Yuan C, Nishihara R, Zoltick E, et al
    Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30683.
    >> Share

    February 2017
  54. KIRANA C, Ruszkiewicz A, Stubbs RS, Hardingham JE, et al
    Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30667.
    >> Share

  55. JERZAK KJ, Berry S, Ko YJ, Earle C, et al
    Cetuximab plus Irinotecan versus Panitumumab in Patients with refractory metastatic colorectal cancer in Ontario, Canada.
    Int J Cancer. 2017 Feb 21. doi: 10.1002/ijc.30637.
    >> Share

  56. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    >> Share

  57. FASANELLI F, Zugna D, Giraudo MT, Krogh V, et al
    Abdominal adiposity is not a mediator of the protective effect of Mediterranean Diet on colorectal cancer.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30653.
    >> Share

  58. MORRIS SM, Davison J, Carter KT, O'Leary RM, et al
    Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Int J Cancer. 2017;140:853-863.
    >> Share

  59. CUBIELLA J, Digby J, Rodriguez-Alonso L, Vega P, et al
    The FAST (Faecal Haemoglobin Concentration, Age and Sex Test) Score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30639.
    >> Share

    January 2017
  60. HERBST A, Vdovin N, Gacesa S, Philipp A, et al
    Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30625.
    >> Share

  61. WALTER V, Jansen L, Knebel P, Chang-Claude J, et al
    Physical activity and survival of colorectal cancer patients: Population-based study from Germany.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30619.
    >> Share

  62. ERTEM FU, Zhang W, Chang K, Mohaiza Dashwood W, et al
    Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
    Int J Cancer. 2017;140:460-468.
    >> Share

    December 2016
  63. ZAMORA-ROS R, Barupal D, Rothwell JA, Jenab M, et al
    Dietary Flavonoid Intake and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30582.
    >> Share

  64. SEFRIOUI D, Vermeulin T, Blanchard F, Chapusot C, et al
    Copy Number Variations in DCC/18q and ERBB2/17q are Associated with Disease-Free Survival in Microsatellite Stable Colon Cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30584.
    >> Share

  65. MORI K, Toiyama Y, Otake K, Fujikawa H, et al
    Proteomics analysis of differential protein expression identifies Heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30557.
    >> Share

  66. WANG C, Wang Z, Zhou J, Liu S, et al
    TUC.338 promotes invasion and metastasis in colorectal cancer.
    Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30542.
    >> Share

    November 2016
  67. BURON PUST A, Alison R, Blanks R, Pirie K, et al
    Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.
    Int J Cancer. 2016 Nov 18. doi: 10.1002/ijc.30527.
    >> Share

  68. ALGARS A, Sundstrom J, Lintunen M, Jokilehto T, et al
    EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30507.
    >> Share

  69. CHEN Y, Xie Y, Xu L, Zhan S, et al
    Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
    Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30496.
    >> Share

    October 2016
  70. MOMEN-HERAVI F, Babic A, Tworoger SS, Zhang L, et al
    Periodontal disease, tooth loss, and colorectal cancer risk: Results from the Nurses' Health Study.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30486.
    >> Share

  71. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    >> Share

  72. WANG N, Khankari NK, Cai H, Li HL, et al
    Pre-diagnosis Body Mass Index and Waist-Hip Circumference Ratio in Association with Colorectal Cancer Survival.
    Int J Cancer. 2016 Oct 5. doi: 10.1002/ijc.30459.
    >> Share

    September 2016
  73. SCLAFANI F, Kim TY, Cunningham D, Kim TW, et al
    Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
    Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30453.
    >> Share

  74. SIMONS CC, Schouten LJ, Godschalk RW, van Engeland M, et al
    Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study.
    Int J Cancer. 2016 Sep 20. doi: 10.1002/ijc.30439.
    >> Share

  75. MAIERTHALER M, Benner A, Hoffmeister M, Surowy H, et al
    Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30433.
    >> Share

  76. VAN ERNING FN, Janssen-Heijnen ML, Creemers GJ, Pruijt JF, et al
    Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30423.
    >> Share

  77. PARK C, Kim JI, Hong SN, Jung HM, et al
    A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in Korean population.
    Int J Cancer. 2016 Sep 8. doi: 10.1002/ijc.30421.
    >> Share

    August 2016
  78. PENG F, Hu D, Lin X, Chen G, et al
    Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30404.
    >> Share

  79. LI Q, Wei P, Huang B, Xu Y, et al
    MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30388.
    >> Share

  80. HASHIMOTO M, Kobayashi T, Tashiro H, Arihiro K, et al
    h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Int J Cancer. 2016;139:812-23.
    >> Share

  81. TAKAHASHI Y, Sugai T, Habano W, Ishida K, et al
    Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30377.
    >> Share

    July 2016
  82. JARY M, Lecomte T, Bouche O, Kim S, et al
    Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: A simple biological score.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30367.
    >> Share

  83. SALIMZADEH H, Bishehsari F, Amani M, Ansari R, et al
    Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-based Study.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30366.
    >> Share

  84. ZHANG X, Keum N, Wu K, Smith-Warner SA, et al
    Calcium intake and colorectal cancer risk: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jul 28. doi: 10.1002/ijc.30293.
    >> Share

  85. WEIGL K, Jansen L, Chang-Claude J, Knebel P, et al
    Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.
    Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30284.
    >> Share

    Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.
    Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30244.
    >> Share

  87. KAHLERT UD, Mooney SM, Natsumeda M, Steiger HJ, et al
    Targeting Cancer Stem-like Cells in Glioblastoma and Colorectal Cancer through Metabolic Pathways.
    Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30259.
    >> Share

    June 2016
  88. KANTOR ED, Zhang X, Wu K, Signorello LB, et al
    Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jun 30. doi: 10.1002/ijc.30250.
    >> Share

  89. LAM-BOER J', Van der Geest LG, Verhoef C, Elferink ME, et al
    Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in The Netherlands.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30240.
    >> Share

  90. MEULENDIJKS D, Henricks LM, Amstutz U, Froehlich TK, et al
    Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
    Int J Cancer. 2016;138:2752-61.
    >> Share

  91. ALLAIRE JM, Roy SA, Ouellet C, Lemieux E, et al
    Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation.
    Int J Cancer. 2016;138:2700-12.
    >> Share

    May 2016
  92. DUFFY AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, et al
    Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.
    Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30199.
    >> Share

    April 2016
  93. VILLACIS RA, Miranda PM, Gomy I, Santos EM, et al
    Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
    Int J Cancer. 2016;138:1928-35.
    >> Share

  94. UBILLOS L, Freire T, Berriel E, Chiribao ML, et al
    Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
    Int J Cancer. 2016;138:1719-31.
    >> Share

  95. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
    Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Int J Cancer. 2016;138:1777-84.
    >> Share

  96. SAKAI E, Fukuyo M, Ohata K, Matsusaka K, et al
    Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Int J Cancer. 2016;138:1634-44.
    >> Share

    March 2016
  97. LOES IM, Immervoll H, Sorbye H, Angelsen JH, et al
    Impact of KRAS, BRAF, PIK3CA, TP53 status and intra-individual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30089.
    >> Share

  98. KANGWAN N, Kim YJ, Han YM, Jeong M, et al
    Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
    Int J Cancer. 2016;138:1482-93.
    >> Share

  99. RENAUD F, Mariette C, Vincent A, Wacrenier A, et al
    The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Int J Cancer. 2016;138:1472-81.
    >> Share

  100. IZANO M, Wei EK, Tai C, Swede H, et al
    Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Int J Cancer. 2016;138:1118-28.
    >> Share

  101. DE CUBA EM, Snaebjornsson P, Heideman DA, van Grieken NC, et al
    Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    Int J Cancer. 2016;138:1139-45.
    >> Share

  102. BU Y, Li X, He Y, Huang C, et al
    A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
    Int J Cancer. 2016;138:1186-98.
    >> Share

    February 2016
  103. MEGE D, Panicot-Dubois L, Ouaissi M, Robert S, et al
    The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
    Int J Cancer. 2016;138:939-48.
    >> Share

    January 2016
  104. HOBAUS J, Tennakoon S, Heffeter P, Groeschel C, et al
    Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy.
    Int J Cancer. 2016;138:440-50.
    >> Share

  105. CARR PR, Walter V, Brenner H, Hoffmeister M, et al
    Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis.
    Int J Cancer. 2016;138:293-302.
    >> Share

    August 2015
  106. AMAYIRI N, Tabori U, Campbell B, Bakry D, et al
    High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
    Int J Cancer. 2015 Aug 8. doi: 10.1002/ijc.29724.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016